For many patients, the active part of an IVF cycle takes about two to three weeks. Ovarian stimulation usually lasts 8 to 14 days, followed by egg retrieval. A fresh embryo transfer may occur several days later, while genetic testing or a frozen embryo transfer makes the overall timeline longer. Pre-treatment testing and cycle scheduling also add time.

IVF is usually experienced as a series of temporary discomforts rather than continuous pain. Injections may sting, and ovarian stimulation can cause bloating or pelvic pressure. Egg retrieval is performed with pain medication, sedation or anesthesia; cramping or soreness can occur for a day or two afterward. Embryo transfer is usually painless, although mild cramping is possible.

No. Routine bed rest after embryo transfer has not been shown to improve pregnancy or live-birth rates. Most patients can walk, use the bathroom and resume normal light activity. Follow your care team’s instructions about strenuous exercise, intercourse, medications and any symptoms that require a call.

No. Medication or IUI may be reasonable first options when the fallopian tubes are open and sperm-related factors are mild. IVF may be recommended sooner for blocked or damaged tubes, more significant sperm-related infertility, diminished ovarian reserve, age-related time concerns, certain genetic-testing needs or unsuccessful prior treatment. Testing and medical history determine the recommendation.

ICSI is a laboratory technique in which an embryologist injects one sperm directly into an egg. It is commonly considered when sperm count or movement is low, sperm must be surgically retrieved, or a previous cycle had poor or failed fertilization. ICSI can help fertilization in selected cases, but it does not guarantee embryo development or pregnancy and is not automatically necessary for every IVF cycle.

Yes. Preimplantation genetic testing can examine cells from an embryo before transfer. PGT-A looks at chromosome number, while PGT-M or PGT-SR may be used for specific inherited or structural chromosome conditions.

The age of the person providing the eggs is one of the strongest predictors of IVF success. Ovarian reserve and response, sperm factors, embryo development, genetic factors, the uterine environment, infertility diagnosis and previous pregnancy or IVF history also matter. Clinic averages do not predict one patient’s result; testing and treatment response are needed for an individualized estimate.

There is no reliable way to promise a specific number before treatment. Some patients achieve a pregnancy after one retrieval and transfer, while others need additional transfers or retrievals. Age, ovarian response, the number of mature eggs, fertilization, embryo development and transfer outcomes help the physician update the estimate after each stage or cycle.

Coverage differs by plan and by stage of treatment. A plan may cover diagnostic testing or medication but exclude egg retrieval, laboratory procedures, embryo transfer or storage. Confirm each benefit, exclusion, prior-authorization requirement and participating provider directly with the insurer. AFMC can help you review available benefits and financial resources.